Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury.

OBJECTIVES This study sought to develop a 2-dimensional (2D) intravascular near-infrared fluorescence (NIRF) imaging strategy for investigation of arterial inflammation in coronary-sized vessels. BACKGROUND Molecular imaging of arterial inflammation could provide new insights into the pathogenesis of acute myocardial infarction stemming from coronary atheromata and implanted stents. Presently, few high-resolution approaches can image inflammation in coronary-sized arteries in vivo. METHODS A new 2.9-F rotational, automated pullback 2D imaging catheter was engineered and optimized for 360° viewing intravascular NIRF imaging. In conjunction with the cysteine protease-activatable imaging reporter Prosense VM110 (VisEn Medical, Woburn, Massachusetts), intra-arterial 2D NIRF imaging was performed in rabbit aortas with atherosclerosis (n =10) or implanted coronary bare-metal stents (n = 10, 3.5-mm diameter, day 7 post-implantation). Intravascular ultrasound provided coregistered anatomical images of arteries. After sacrifice, specimens underwent ex vivo NIRF imaging, fluorescence microscopy, and histological and immunohistochemical analyses. RESULTS Imaging of coronary artery-scaled phantoms demonstrated 8-sector angular resolution and submillimeter axial resolution, nanomolar sensitivity to NIR fluorochromes, and modest NIRF light attenuation through blood. High-resolution NIRF images of vessel wall inflammation with signal-to-noise ratios >10 were obtained in real-time through blood, without flushing or occlusion. In atherosclerosis, 2D NIRF, intravascular ultrasound-NIRF fusion, microscopy, and immunoblotting studies provided insight into the spatial distribution of plaque protease activity. In stent-implanted vessels, real-time imaging illuminated an edge-based pattern of stent-induced arterial inflammation. CONCLUSIONS A new 2D intravascular NIRF imaging strategy provides high-resolution in vivo spatial mapping of arterial inflammation in coronary-sized arteries and reveals increased inflammation-regulated cysteine protease activity in atheromata and stent-induced arterial injury.

[1]  Vasilis Ntziachristos,et al.  In Vivo Imaging of Proteolytic Activity in Atherosclerosis , 2002, Circulation.

[2]  Ralph Weissleder,et al.  Molecular imaging of cardiovascular disease. , 2007, Circulation.

[3]  F. Jaffer,et al.  Emerging Molecular Targets for Intravascular Imaging of High-Risk Plaques , 2010 .

[4]  Benjamin J Vakoc,et al.  Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. , 2008, JACC. Cardiovascular imaging.

[5]  E. Edelman,et al.  Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.

[6]  Aloke V. Finn,et al.  Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study , 2008, Circulation.

[7]  Vasilis Ntziachristos,et al.  Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques. , 2010, Journal of biomedical optics.

[8]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[9]  J. Slakter,et al.  Adverse Reactions due to Indocyanine Green , 1994 .

[10]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[11]  Vasilis Ntziachristos,et al.  Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis , 2008, Circulation.

[12]  Jean-Claude Tardif,et al.  In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. , 2009, JACC. Cardiovascular imaging.

[13]  P. Teirstein,et al.  Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry , 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[14]  Michael Joner,et al.  Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications , 2007, Circulation.

[15]  Vasilis Ntziachristos,et al.  Transillumination fluorescence imaging in mice using biocompatible upconverting nanoparticles. , 2009, Optics letters.

[16]  P. Libby,et al.  Lysosomal Cysteine Proteases in Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Daniel J. Rader,et al.  Translating molecular discoveries into new therapies for atherosclerosis , 2008, Nature.

[18]  Vasilis Ntziachristos,et al.  Normalized Born ratio for fluorescence optical projection tomography. , 2009, Optics letters.

[19]  James E. Moore Biomechanical Issues in Endovascular Device Design , 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[20]  Vasilis Ntziachristos,et al.  Near-infrared fluorescence catheter system for two-dimensional intravascular imaging in vivo. , 2010, Optics express.

[21]  M. Daemen,et al.  Cathepsin cysteine proteases in cardiovascular disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  P. Libby Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.